Objectives To identify the prevalence of anaemia in Chinese type 2 diabetic patients managed in a primary care setting and to explore its associations with cardiovascular complications and kidney disease.
貧血與二型糖尿病：來自基層醫護回顧性病例 系列研究的啟示

Introduction
Type 2 diabetes mellitus is one of the most common chronic conditions encountered in primary care, and affects up to 10% of the Hong Kong population. 1 It is also a leading cause of morbidity and mortality due to complications, including kidney disease, blindness, lower limb amputation, and coronary heart disease. 2 Its increasing prevalence has placed greater demands on health care systems and carers.
Anaemia is a common concomitant condition among such patients, with a prevalence that varies in different ethnic groups, ranging from 20% in tertiary referral clinics in Australia, 3 and up to 45% in Caribbean type 2 diabetic patients. 4 The greatest decrease in haemoglobin (Hb) levels was noted in patients with macroalbuminuria and renal impairment. Indeed, anaemia is a well-known complication of chronic kidney disease (CKD) and is now recognised as an early component of diabetic nephropathy. 5 In addition, chronic anaemia is also regarded as a risk factor for cardiovascular disease (CVD) outcomes in diabetes. 6 Locally, a significant proportion of type 2 diabetic patients are managed in primary care and followed up at government General Out-patient Clinics (GOPCs) of the Hospital Authority. A group of endocrinologists from The Chinese University of Hong Kong had examined the association between haematocrit and cardiovascular events in a cohort of Chinese type 2 diabetic patients followed up in their specialist out-patient setting. 7 They found that low levels of haematocrit and the presence of CKD were associated with an increased risk of adverse cardiovascular events. However, local data on the prevalence of anaemia and its clinical significance in Chinese type 2 diabetic patients managed in primary care are still lacking. The clinic where the authors are working is one of the biggest GOPCs of the Hong Kong Hospital Authority; more than 70% of patients attending the clinic have chronic diseases including New knowledge added by this study • Anaemia is common in Chinese type 2 diabetic patients managed in primary care; 1 in 4 such patients will have anaemia.
• The prevalence of anaemia increased significantly with deterioration of renal function; 54% of such patients had anaemia if they had chronic kidney disease (estimated glomerular filtration rate [eGFR] of <60 mL/min/1.73 m 2 ).
• Compared with diabetic patients with normal haemoglobin values, those who were anaemic had a higher co-morbidity rate for stroke, ischaemic heart disease (IHD), hypertension, and chronic kidney disease.
• Among these patients, male gender, old age, increased serum creatinine level, decreased eGFR, elevated urine albumin-creatinine ratio, and co-morbidity due to stroke or IHD were all associated with greater odds for the presence of anaemia.
Implications for clinical practice or policy
• The high prevalence of anaemia among Chinese type 2 diabetic patients should alert family physicians to the importance of routine screening and regular monitoring for anaemia for such patients, including those without overt nephropathy.
• Early detection of anaemia and prompt referral to specialist care for optimal treatment, if associated with severe renal impairment or high-risk proteinuria in the primary care settings, may help reduce future cardiovascular events and hospital admissions, and improve their well-being and quality of life.
diabetes. To address this knowledge gap, we set out to identify the prevalence of anaemia among Chinese type 2 diabetic patients in the primary care setting and explore its associations with cardiovascular complications and kidney disease.
Methods
Study design
This was a retrospective case series study of Chinese type 2 diabetic patients regularly followed up at the Yau Ma Tei GOPC of the Kowloon Central Cluster.
Subjects
All Chinese type 2 diabetic patients having the International Classification of Primary Care (ICPC) code T90, who had been regularly followed up in this clinic between 1 January 2010 and 31 December 2011, and had annual blood and urine checkups at least once during that period were recruited. The diagnosis of diabetes was based on the "Definition and description of diabetes mellitus" from American Diabetes Association in 2010. 8 In this clinic, diabetic patients were usually provided with blood and urine checkups at least annually to every 18 months. This 2-year retrieval period was therefore likely to cover all such patients regularly followed up in this clinic. Wrongly diagnosed diabetic patients, type 1 diabetic patients, diabetic patients who were not Chinese, and patients who had not had an annual checkup within this period were excluded.
Definition of anaemia
According to the World Health Organization (WHO) gender-specific criteria, 9 anaemia in this study was defined as a Hb level of <130 g/L in men and <120 g/L in women. Anaemia was defined as normocytic with a mean corpuscular volume (MCV) of 80 to 100 fL, microcytic if the MCV was <80 fL, and macrocytic if the MCV was >100 fL.
Determination of variables
Each recruited patient's age, gender, smoking status, body mass index (BMI), complete blood picture reports, serum creatinine (Cr) and blood haemoglobin A1c (HbA1c) levels, as well as urine albumin-creatinine ratio (ACR) were retrieved from the Clinical Management System (CMS) of the Hospital Authority. The most recent blood test that included a complete blood picture was used for analysis if more than one test had been performed during the study period. The BMI was calculated as body weight (kg)/body weight 2 (m 2 ). The patient was considered a smoker if he/she currently smoked or was within the first 6 months of quitting. where SCR is the serum Cr expressed as μmol/L. 10 Chronic kidney disease was defined as having an eGFR of <60 mL/min/1.73 m 2 .
Microalbuminuria was defined as albumin secretion of 30 to 300 mg/24 h and macroalbuminuria or proteinuria as a value of >300 mg/24 h. According to the American Diabetes Association guideline, 11 screening for microalbuminuria can be performed by measurement of urine ACR in a random spot collection. As suggested by the Scottish Intercollegiate Guidelines Network on the management of diabetes (March 2010), normoalbuminuria was defined as a urine ACR of <2.5 mg/mmol in males and <3.5 mg/mmol in females. 12 Corresponding values for microalbuminuria were defined as 2.5 to 30 mg/mmol for males and 3.5 to 30 mg/mmol for females, and for macroalbuminuria they were >30 mg/mmol for both sexes. 12 An elevated urine ACR needed to be confirmed in the absence of urinary tract infection with additional first-void specimens collected during the next 3 to 6 months. Due to the high associated risk, patients with urine ACRs of ≥150 mg/mmol were considered a separate group.
A medical history of stroke, ischaemic heart disease (IHD), and concomitant hypertension (HT) were retrieved using the ICPC code from the CMS. For stroke cases, the ICPC codes were K89 (transient ischaemic attack), K90 (cerebrovascular accident), and K91 (cerebrovascular disease). The HT ICPC codes were K86 (uncomplicated) and K87 (complicated), whereas the IHD ICPC codes were K74 (IHD with angina), K75 (acute myocardial infarction), and K76 (IHD without angina). Repeat systolic blood pressures of ≥130 mm Hg or diastolic blood pressures of ≥80 mm Hg confirmed a diagnosis of HT in diabetic patients.
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Statistical analysis
All data were entered and analysed using computer software (Windows version 16.0; SPSS Inc, Chicago [IL], US). Student's t test and analysis of variance were used for analysing continuous variables and the Chi squared test for categorical data. Pearson's correlation and multivariate logistic regression were used to determine the association between Hb levels and different variables including age, gender, serum Cr, eGFR, urine ACR, and co-morbidities such as stroke, IHD, or HT. All statistical tests were twosided, and a P value of less than 0.05 was considered significant.
Results
A total of 7481 type 2 diabetic patients followed up in our clinic between 1 January 2010 and 31 December 2011 was generated from the CMS. Among them, 1156 (16%) patients were excluded based on the exclusion criteria. These patients included 5 wrongly diagnosed as diabetic, 1 with type 1 diabetes, 499 who were not Chinese, and 651 who had not had their blood and urine checked during the recruitment period. Thus, 6325 patients fulfilling the inclusion criteria were recruited into this study.
Among these recruits, 1441 patients were found to have anaemia during the study period, giving a period prevalence of 22.8%. Table 1 summarises the demographic characteristics of these diabetic patients with or without anaemia. In summary, they were comparable in terms of male-to-female ratio, smoking status, and BMI (all P>0.05). However, the anaemic group was significantly older, the mean ± standard deviation (SD) age being 70.9 ± 11.4 years (vs non-anaemic group, 62.9 ± 11.6 years; P<0.001).
Pattern of anaemia in anaemic diabetic patients
Among the 1441 diabetic patients who were anaemic (as defined by gender-specific WHO criteria), more than half had a normocytic (n=879, 61%) type, whilst fewer were microcytic (n=392, 27%) or macrocytic (n=170, 12%). Among those with microcytic anaemia and iron profile or Hb pattern checked (n=335), 76 had iron deficiency and 32 (23 females and 9 males) had thalassaemia minor. Among those with macrocytic anaemia who had their serum vitamin B12 level checked (n=106), 46 had vitamin B12 deficiency. Table 2 summarises the glycaemic control, kidney function, and presence of concomitant diseases in these diabetic patients with or without anaemia. Diabetic patients with normal Hb levels had a significantly higher mean (± SD) HbA1c level than those who were anaemic (7.4 ± 1.4% vs 7.3 ± 1.4%; P=0.003). With regard to kidney function, mean serum Cr level of the anaemic groups was significantly higher than that of the non-anaemic patients, with a mean eGFR that was significantly lower than that in the latter group. In addition, among diabetic patients with and without anaemia, the proportions suffering from microalbuminuria, macroalbuminuria, and high-risk proteinuria were invariably higher in the anaemic group (all P<0.001).
When co-morbidity due to cardiovascular and CKD was compared, they too were more common in the anaemic than non-anaemic diabetic patients. The corresponding proportions were 11% versus 6% for stroke, 7% versus 4% for IHD, 82% versus 75% for HT, and 36% versus 9% for CKD (all P<0.001). Figure 2 describes the prevalence of anaemia in patients with diabetes according to eGFR. Stratification by gender revealed parallel trends in both sexes. The prevalence increased significantly with deterioration of renal function. Thus, 93% of male and 86% of female patients with eGFRs of <30 mL/min/1.73 m 2 were anaemic, while the respective proportions for males and females were 51% and 50% for those with eGFRs of 30 to 59 mL/min/1.73 m 2 , and 22% and 21% for those with eGFRs of 60 to 89 mL/ min/1.73 m 2 . The corresponding proportions were all significantly higher (P<0.001) than those with eGFRs of >90 mL/min/1.73 m 2 (12% of male and 14% female).
Predictors of haemoglobin level
In this cohort of Chinese diabetic patients, the mean (± SD) Hb level was 139 ± 16 g/L for males and 128 ± 13 g/L for females (P<0.01). Pearson's correlation analysis showed that independent predictors for Hb among these diabetic patients were age (r= -0.34), gender (males had significantly higher Hb levels), serum Cr (r= -0.22), eGFR (r=0.30), HbA1c (r=0.06), and urine ACR (r= -0.12) [all P<0.001; Table 3] . When the Hb level was dichotomised as anaemia and nonanaemia and the data were submitted to multivariate logistic regression analyses, the results showed that male gender, older age, increased serum Cr, reduced eGFR, elevated urine ACR, and co-morbidity with stroke or IHD were all associated with greater odds for the presence of anaemia (Table 4) , while HbA1c and concomitant HT had no association with the anaemic status.
Discussion
We believe this locally conducted study, which described the prevalence of anaemia and its predictors in Chinese diabetic patients managed in primary care, is the largest clinical analysis of anaemic conditions among Chinese type 2 diabetic patients to date.
Both locally and worldwide, anaemia is a common concern in geriatric health but its exact prevalence remains unclear. Several studies have addressed this issue with discrepant results. Locally, one study reported the prevalence of anaemia among Chinese geriatric subjects (defined as those aged >60 years) and found it to be 6.4% and 6.3% respectively among men and women with co-morbidity including haemoglobinopathies.
14 Our study revealed that anaemia was commonly present in Chinese diabetic patients managed in local primary care facilities, with a period prevalence of up to 23%. This is much higher than that in the general geriatric population and may represent a significant unrecognised burden. This prevalence is comparable to that reported in diabetic patients in Australia, 5 but was much lower than that reported in the US (34.7%) 15 and in Caribbeans (46.5%). 4 The disparity could be partially explained by different degrees of diabetes severity managed in primary and secondary care in these regions. Diabetic patients with stable metabolic control and less severe complications are more likely to be managed in the primary care and therefore have a lower prevalence of anaemia compared with those managed in secondary or tertiary settings. In addition, ethnicity plays a part in the liability to anaemia and might account for some of the observed ethnic disparities. 16 Anaemia has the potential to adversely affect the health status of diabetic patients in different ways. Studies have shown that patients with anaemia generally have a low quality of life compared with those who are non-anaemic. In addition, their sense of well-being including working and social lives may be adversely affected. 17 Reasons for anaemia among diabetic patients are multifactorial. Most of our anaemic patients were normocytic (61%), whilst fewer were microcytic (27%) and macrocytic (12%). The most common cause is anaemia due to chronic diseases including HT, IHD, stroke and CKD, and less often they have iron deficiency, thalassaemia minor or vitamin B12 deficiency. However, since this study was carried out in the primary care setting, many patients with anaemia were not worked up, and therefore their underlying pathology remained unknown. Further studies into possible reasons for iron or B12 deficiency in these patients are needed. When patients were stratified according to eGFR, not surprisingly, the prevalence of anaemia increased significantly with deterioration of renal function. Thus, in this study 54% of diabetic patients with CKD were anaemic, which was significantly higher than those without CKD (P<0.001). In addition, anaemic diabetic patients were more likely to have concomitant diabetic nephropathy with microalbuminuria, macroalbuminuria, and high-risk proteinuria (Table 2) . Impaired renal erythropoietin release in response to declining Hb levels has been postulated to be the major contributor accounting for the presence of anaemia among such patients. 18 Other causes include occult blood loss, malnutrition, hyperparathyroidism, systemic inflammation, and reduced red cell survival. 19 In patients with CKD, the presence of anaemia contributes significantly to morbidity, causing symptoms such as lack of energy, poor appetite, and dizziness. 20 On the other hand, anaemia was not confined to diabetic patients who had renal impairment; 12.6% of these diabetic patients had anaemia with what could be called "normal renal function" (eGFR >90 mL/min/1.73 m 2 ). The presence of anaemia, whatever the cause, helps to identify those at a greater risk for adverse outcomes.
Further studies into the co-morbidity of diabetic patients revealed that a much higher proportion of anaemic diabetics had a history of stroke, IHD, and HT compared with those who were non-anaemic (all P<0.001). These data suggest that such anaemia might be attributable to the development of cardiovascular complications in diabetic patients, but must be interpreted with caution since age might be an important confounder. In this study, the anaemic diabetic patients were significantly older than those with a normal Hb level (70.9 ± 11.4 vs 62.9 ± 11.6 years; P<0.001) [ Table 1 ]. Older age is an established cardiovascular risk factor in all populations besides predisposing to anaemia. 21 Therefore, future studies need to stratify diabetic patients according to different age-groups, so as to better establish the relationship between anaemia and concomitant CVDs. Nevertheless, studies carried out in the 23 and heart failure 24 showed that chronic anaemia is an independent risk factor for CVD events. It has been postulated that long-term anaemia might predispose to adverse CVD outcomes, by virtue of ventricular remodelling, cardiac dysfunction, and left ventricular hypertrophy. 25 Other possibilities included decreased nutritional status and increased inflammation in the presence of chronic anaemia. 26 Anaemia, CKD, and cardiovascular complications may therefore act together in a vicious circle, in which one condition causes or exacerbates the other.
With regard to predictors of the Hb level, multivariate logistic regression analyses showed that male gender, old age, increased serum Cr level, reduced eGFR, elevated urine ACR, and co-morbidity due to stroke or IHD were all associated with greater odds for the presence of anaemia (Table 4) . This result was similar with findings from the follow-up of diabetic patients in the specialist clinic in Australia, 5 and helps us to easily identify diabetic patients that were more likely to have anaemia and therefore in need of early intervention. They also emphasise the importance of checking eGFR in the management of diabetic patients, particularly in the elderly whose apparently "normal renal function" could be related to reduced muscle mass.
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Implications for primary care
Family physicians are at the forefront in the management of type 2 diabetes, and aim to achieve optimal metabolic control to prevent macro-and micro-vascular complications. This study has provided important background information on the high prevalence of anaemia among Chinese type 2 diabetic patients. It also alerts family physicians to the importance of routine screening and regular monitoring for anaemia in primary care, including for patients without overt nephropathy. This is particularly important in busy GOPCs, where haematological tests were not routinely performed as part of the annual assessment. We believe that regular monitoring of the Hb level in type 2 diabetic patients, together with early detection of anaemia and prompt referral to specialist care if associated with severe renal impairment or high-risk proteinuria at the primary care settings, would help to reduce their cardiovascular events, hospital admissions, and therefore improve their well-being and quality of life.
Limitations of this study
Firstly, only diabetic patients who had been regularly followed up in this single clinic and who had annual blood and urine checks at least once during this 2-year period were recruited. Those who never attended the annual assessment whatever the reason were excluded. This could have introduced a selection bias. Secondly, all variables were measured at least once during the 2-year study period. When more than one blood test had been performed, the most recent test that included a complete blood count was used for analysis. Therefore, variability of finding may confound the effect of covariates on outcomes. Thirdly, concomitant chronic diseases (HT, IHD, and stroke) were retrieved via the ICPC code in the CMS, so that inadequate coding may underestimate such co-morbidity in both the normal Hb and anaemia groups. In addition, the duration of diabetes could be an important attributing factor to the presence of anaemia. Regrettably, we had difficulties in compiling these data, since they were not retrievable for diabetic patients due to poor documentations in the CMS, and therefore were not included in this study. Lastly, because of the cross-sectional nature of our study, we were unable to adjust for potential unmeasured confounders and therefore no temporal or causal relationship could be established.
Conclusion
In summary, anaemia is commonly present among Chinese type 2 diabetic patients, particularly those with impaired renal function, diabetic nephropathy, or CVDs. Therefore, we recommend regular monitoring of the Hb level among diabetic patients in primary care settings to enable early detection of anaemia and prompt referral to specialist care for optimal treatment. Such a policy appears especially important for patients with severe renal impairment or high-risk proteinuria.
